In a series of N+ ER-positive (ER+, by ligand-binding assay, LBA) postmenopausal women with resectable breast cancer who received adjuvant tamoxifen, we investigated the comprehensive effect on RFS of VEGF content and steroid receptor profile, evaluated in the same cytosolic fraction. This evidence concerns the gene VEGFA and breast carcinoma.